GDF10

Across TCGA pan-cancer cohorts, GDF10 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GDF10 data layer compared with 24 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher GDF10 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated GDF10 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.

HNSC, LUAD, and LSCC are the cancer types where GDF10 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Quartile	III,IV	0.864	0.571	.021	4	view →
LUAD	OS	Quartile	III,IV	0.164	0.866	.035	4	view →
LSCC	DFS	Quartile	II,III,IV	0.831	0.310	.024	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

GDF10–HNSC (DFS)

Open the HNSC breakdown →